logo

For the Inventor, By the Inventor

Brunswick, Australia

Ian F C McKenzie

This inventor holds 5 USPTO granted patents. Top assignees: Ilexus Pty Limited, The Macfarlane Burnet Institute for Medical Research and Public Health Limited, Other. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian F C McKenzie. Retrieved from https://idiyas.com/inventor/ian-f-c-mckenzie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Pt. Lonsdale, AU (2009)
  • Brunswick, AU (2002 - 2014)

Company Filing History:

goldMedal2 out of 4 
 
Ilexus Pty Limited
 patents
silverMedal2 out of 11 
 
The Macfarlane Burnet Institute for Medical Research and Public Health Limited
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 2002-2014

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8771701 - Compositions for immunotherapy and uses thereof (2014-07-08),
2. 8021667 - Compositions for immunotherapy and uses thereof (2011-09-20),
3. 7553809 - Fc receptor modulators and uses thereof (2009-06-30),
4. 6675105 - Structure-based identification of candidate compounds using three dimensional structures and models of Fc receptors (2004-01-06),
5. 6455037 - Cells expressing an &agr;gala nucleic acid and methods of xenotransplantation (2002-09-24),

As a specialist in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide a comprehensive article about inventor Ian F C McKenzie from Brunswick, AU.

Title: Ian F C McKenzie - Revolutionizing Immunotherapy

Introduction:

Ian F C McKenzie, a prolific inventor hailing from Brunswick, AU, has made significant contributions to the field of immunotherapy through his groundbreaking patented inventions.

Latest Patents:

1. "Compositions for Immunotherapy and Uses Thereof": Ian's innovative method involves eliciting a cytotoxic T lymphocyte response by pulsing mannose receptor-bearing antigen-presenting cells with a conjugate comprising an antigen and a carbohydrate polymer containing mannose. This method holds great promise in enhancing immune responses in animals.

2. "Immunogenic Composition for Immunotherapy": Another invention by Ian involves an immunogenic composition comprising a conjugate between an antigen and an oxidized mannan with aldehyde groups, providing a novel approach to immunotherapy.

Career Highlights:

Ian F C McKenzie has showcased his expertise and passion for innovation through his work with reputable companies such as Ilexus Pty Limited and The Macfarlane Burnet Institute for Medical Research and Public Health.

Collaborations:

During his illustrious career, Ian has collaborated with esteemed professionals in the field, including Geoffrey Alan Pietersz and P Mark Hogarth. Together, they have pushed the boundaries of immunotherapy research and development.

Conclusion:

In conclusion, Ian F C McKenzie's dedication to advancing immunotherapy through his patented inventions reflects his commitment to driving positive change in the medical field. His relentless pursuit of innovation continues to inspire and shape the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…